Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Treatment and Outcome of Children With Neuroblastoma in India: Report From the InPOG-NB-18-01 India Neuroblastoma Registration Study.
Journal: Pediatric blood & cancer
Published: March 06, 2026
Low-Dose Intravenous Ketamine for Primary Pain Control During Naxitamab Anti-GD2 Immunotherapy Treatment.
Journal: Pediatric blood & cancer
Published: January 06, 2026
The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis.
Journal: The Lancet regional health. Southeast Asia
Published: December 09, 2025
Early Detection of Neuroblastoma Recurrence on 18 F m FBG PET.
Journal: Clinical nuclear medicine
Published: November 05, 2025
A pharmacological and clinical profile of Naxitamab for the treatment of high-risk neuroblastoma.
Journal: Expert review of clinical pharmacology
Published: October 20, 2025
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remission.
Journal: International journal of cancer
Published: October 03, 2025
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remission.
Journal: International journal of cancer
Published: September 24, 2025
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial.
Journal: Journal of hematology & oncology
Published: September 22, 2025
Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.
Journal: Nature communications
Published: September 03, 2025
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.
Journal: Nature genetics
Published: August 06, 2025
Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: August 01, 2025
Clinical Significance of TERT Promoter Mutations in Neuroblastoma.
Journal: JCO precision oncology
Published: July 10, 2025
Last Updated: 09/26/2026